Dr. Moore’s research has been focused on the hormonal control of blood pressure in normal and hypertensive subjects, especially the renin-angiotensin system. He was involved in some of the early studies of converting enzyme inhibitors and angiotensin receptor antagonists. He has also focused on the interaction between dietary factors and blood pressure, including salt as well as other minerals and nutrients. He was the chairman of the steering committee of the DASH trial which first described what is now known as the DASH Diet. The DASH diet is a well-balanced diet that has been shown to lower blood pressure, reduce the frequency of heart attacks and strokes, reduce the development of diabetes, and other health benefits. The DASH diet is recommended in high blood pressure guidelines in the US and other countries.
He was the former Associate Provost and Executive Director of the Office of Human Research Affairs for the Boston University Medical Campus. He is Professor of Medicine and Endocrinology at Boston University School of Medicine.
- Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
- Active Staff Privileges, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston Medical Center
- University of Cincinnati, MD
- Xavier University, BA
- Published on 11/18/2010
Svetkey LP, Harris EL, Martin E, Vollmer WM, Meltesen GT, Ricchiuti V, Williams G, Appel LJ, Bray GA, Moore TJ, Winn MP, Conlin PR. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system. Am J Hypertens. 2011 Feb; 24(2):209-17. PMID: 21088669.
- Published on 10/23/2009
Sacks N, Cabral H, Kazis LE, Jarrett KM, Vetter D, Richmond R, Moore TJ. A web-based nutrition program reduces health care costs in employees with cardiac risk factors: before and after cost analysis. J Med Internet Res. 2009; 11(4):e43. PMID: 19861297.
- Published on 1/23/2009
Jacobs DR, Gross MD, Steffen L, Steffes MW, Yu X, Svetkey LP, Appel LJ, Vollmer WM, Bray GA, Moore T, Conlin PR, Sacks F. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Kidney Dis. 2009 Apr; 53(4):638-46. PMID: 19167797.
- Published on 12/12/2008
Moore TJ, Alsabeeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D, Jenkins M, Cabral H. Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J Med Internet Res. 2008; 10(4):e52. PMID: 19073541.
- Published on 1/1/2006
Moore TJ. Arterial hypertension and hypertensive encephalopathy. In Neurological Therapeutics Principles and Practice 2nd Edition. JH Noseworthy (editor-in-chief). Martin Dunitz Press. London. 2006.
- Published on 1/1/2005
Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, Vogt TM, Conlin PR, Proschan M, Harsha D. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens. 2005 Jan; 19(1):77-82. PMID: 15361888.
- Published on 7/1/2004
Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ. Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004 Jul; 6(7):373-81. PMID: 15249792.
- Published on 7/1/2004
Moore TJ. The DASH Diet in the Control of Hypertension. Current Opinion in Endocrinology & Diabetes. 2004.
- Published on 9/2/2003
Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, Svetkey LP, Most-Windhauser MM, Cutler JA. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 2003 Oct; 42(4):459-67. PMID: 12953018.
- Published on 7/1/2003
Sacks FM, Appel LJ, Bray GA, Conlin PR, Moore TJ, Svetkey LP, Vollmer WM. Sodium and blood pressure: no data dredging, please! Am J Hypertens. 2003 Jul; 16(7):614-6. PMID: 12850399.
View 97 more publications: View full profile at BUMC